Alphatec Holdings, Inc.·Healthcare

Aberdeen Group plc boosted its holdings in Alphatec Holdings, Inc. (NASDAQ: ATEC) by 29.7% in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,286,195 shares of the medical technology company's stock after purchasing an additional 294,792 shares during the quarter.

See how a prediction markets trading strategy helps traders anticipate earnings moves and capitalize on pricing gaps.

Craig Hunsaker sold 116,367 shares across two open-market transactions on March 6 and March 9, 2026, for a total of ~$1.44 million at a weighted average price of $12.38 per share. This activity represented 6.32% of Hunsaker's direct holdings prior to the transaction, reducing direct ownership from approximately 1.84 million to 1.73 million shares.

The CFO of Alphatec Holdings reported selling 79,789 shares of the company on March 13, 2026, generating a transaction value of approximately $986,000. This disposition represented 11.7% of John Todd Koning's direct common stock holdings, reducing his direct ownership to 600,721 shares after the trade.

Alphatec Holdings, Inc. (NASDAQ: ATEC - Get Free Report) COO Scott Lish sold 260,535 shares of the stock in a transaction on Friday, March 13th. The shares were sold at an average price of $12.30, for a total transaction of $3,204,580.50. Following the completion of the transaction, the chief operating officer owned 815,704 shares of the

Executives from Alphatec (NASDAQ: ATEC) outlined their view of the spine surgery market, growth drivers, and recent financial progress during a conference discussion featuring Chief Financial Officer Todd Koning and Vice President of Finance and Head of Investor Relations Robert Judd. The conversation touched on investor questions about whether the company can sustain its growth rates
Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders. The company offers SafeOp Neural InformatiX System, an Alpha InformatiX product platform designed to reduce the risk of intraoperative nerve injury; Sigma transforaminal lumbar interbody fusion pedicle-based access system that provides direct visualization of anatomical landmarks; Sigma PTP Access and Patient Positioning System; squadron lateral retractor designed to maximize patient outcomes; Invictus Spinal Fixation System, a thoracolumbar fixation system to treat a range of pathologies; and Invictus MIS SingleStep System that provides minimally invasive pedicle screw placement. It also provides Invictus Modular Fixation Systems designed to increase adaptability with the power of screw modularity; OsseoScrew system to restore the integrity of the spinal column; Arsenal spinal fixation system, a comprehensive thoracolumbar fixation platform to fix a range of degenerative to deformity pathologies and surgical procedures; Aspida Anterior Lumbar Plating System, a fixation system for anterior lumbar interbody fusion; AMP Anti-Migration Plate; OCT Spinal Fixation System; trestle luxe anterior cervical plate system; and Insignia Anterior Cervical Plate System. In addition, the company offers IdentiTi Porous Ti, Transcend Lateral, and Battalion Posterior Interbody Implants; and biologics consisting of Cervical Structural Allograft Spacers, 3D ProFuse Demineralized Bone Scaffold, Neocore Osteoconductive Matrix, Alphagraft Demineralized and Cellular Bone Matrix, and Amnioshield Amniotic Tissue Barrier, as well as EOS imaging products. It sells its products through a network of independent distributors and direct sales representatives in the United States. The company was founded in 1990 and is headquartered in Carlsbad, California.
Healthcare
Medical - Devices
867
2006-06-12
1.12